T1	Outcomes 34 76	thromboxane and prostaglandin biosynthesis
T2	Outcomes 149 226	bradykinin-stimulated prostaglandin (PG) and on thromboxane (TX) biosynthesis
T3	Outcomes 495 521	TXB2 was measured in serum
T4	Outcomes 569 611	Aspirin inhibited bradykinin stimulated PG
T5	Outcomes 663 686	Serum TXB2 remained low
T6	Outcomes 696 718	PG synthesis recovered
T7	Outcomes 828 851	Prostanoid biosynthesis
T8	Outcomes 874 911	Biosynthesis of prostacyclin and TXA2
T9	Outcomes 968 1023	measuring 2,3-dinor-6-oxo-PGF1 alpha and 2,3-dinor-TXB2
T10	Outcomes 1167 1192	reduced urinary excretion
T11	Outcomes 1248 1297	2,3-dinor-6-oxo-PGF1 alpha recovered more rapidly
T12	Outcomes 1370 1422	rapidly synthesised in bradykinin-responsive tissues
